The global healthcare industry comprises different players, including hospitals, physicians, diagnostic laboratories, pharmacies, payers, nursing homes, medical device manufacturers, and other components of the healthcare system. The aging population across the globe and the increasing prevalence of acute and chronic diseases are the fundamental drivers that are creating a demand for various healthcare services, medical equipment, and supplies. Arizton anticipates that there would be a huge demand for various medical devices in the coming years.

The US Food and Drug Administration (FDA) is responsible to ensure that the public health and safety ae not compromised through the products that are intended for human and animal consumption. Hence, FDA laid regulations for maintaining the safety of instruments in calibration services.  The FDA has a code of regulations for medical device calibration requirements, which are stated in part 820 of its Quality System Regulation (QSR), Section 72. Title 21 of Code of Federal Regulations (CFR) part 820.72. This deals with inspection, measuring, and test equipment.  The regulation requirements of FDA for medical device calibration are not for specific measures. The regulations have been designed to ensure that the inspection, measuring, and the test equipment satisfy the intended use and quality requirements. The regulations act as guidelines for the manufacturers and distributors of medical equipment and devices, as they define the procedures, accuracy standards, and frequency of calibration that must be followed for calibrated equipment.

The North America medication adherence packaging market is estimated to grow at a CAGR of 6.3% from 2019 - 2027. Key factors that are driving growth of the market are rising demand for adherence packaging from patients, rising need to minimize medication wastage and growing initiatives by government. However, the market is estimated to experience slower growth due to the high cost of installation and maintenance for medication packaging systems.

Manufacturing represents sophisticated cooperation among different departments of business, such as procurement, engineering, and quality control. As the globalization has been a common phenomenon, effective management of cross-functioning teams becomes a major challenge for most businesses. Manufacturing execution systems (MES) are made for improving manufacturing accuracy and efficiency. These are process-oriented production management systems that are used for the real-time execution of production plans as well as for getting feedback from the processes. They are generally connected to numerous systems at the process automation level. These comprise traditional data collection and all other procedures that have a real-time effect on the process of production. Manufacturing execution systems is a total solution including software and services to enhance factory automation efficiency. The systems provide complete service on automation of the manufacturing system and procurement system. To satisfy customers’ needs, manufacturers are dedicated to offering high-quality products at affordable prices with in time delivery. Thus, enhancing production quality and efficiency is a critical challenge faced by the manufacturers. The manufacturing process starts with material procurement. When all the materials arrive in the warehouse, the assembly process begins. After the device is assembled and passed through the quality control process, all the qualified goods will move to the packing area. Finally, these goods would be shipped out based on the order details. The accuracy of cost estimation, quality record and analysis, progress control of orders, etc., are the major parameters considered to enhance manufacturing efficiency.

Aquaculture includes farming of fish, aquatic plants, algae, crustaceans, molluscs, and other organisms. Small-scale aquaculture market in developed and developing countries make critical contributions to employment. According to the FAO, aquaculture provides employment to more than over 41 million people globally. The vast majority of aquaculture activities are carried out in developing countries working in fish production. Fish and other seafood species constituting an important source of nutrients for the poor and is among the cheapest form of animal protein. As most capture fisheries worldwide considered fully exploited or overexploited, aquaculture is considered as an important sector to meet rising fish demand, which will continue to increase with population growth, rising incomes and increasing urbanization. The aquaculture sector in North America is dominated by finfish and trout, primarily channel catfish in the US of America, Atlantic salmon in Canada. A smaller segment is dedicated to the production of bivalve molluscs shellfish, mainly a number of species of oysters, mussels, and clams. The availability of suitable environment, technology, and financing for the aquaculture industry in this region boost the aquaculture market growth. Rising demand for aquaculture-produced seafood, coupled with increased consumer demand for seafood in the diets of people is expected to propel the aquaculture market in North America. In North America, health benefits of cultured seafood are routinely promoted as part of marketing, and FAO described both Canadian and American government initiatives for promoting the consumption of seafood which propels the demand for seafood in this region

The industry landscape chapter gives a brief knowledge about the various product developments, partnerships, mergers & acquisitions, and collaboration strategies implemented by the companies operating in the application modernization tools market.Market initiative strategy is adopted by the companies to expand their footprints across the world to meet the growing demand of customers. The players operating in the application modernization tools market are focusing on products enhancements by integration of advanced technologies.

The aircraft industry is experiencing considerable demand for various technologically advanced equipment. The inclination curve of air travel is continuously climbing across geographies forcing the manufacturers of aircraft to provide an increased number of aircrafts such as fixed-wing and rotary-wing. The commercial air passenger is expected to maintain a continuous growth over the years, irrespective of numerous challenges faced by the commercial airlines such as aviation fuel price, and other monetary changes in various countries. However, these challenges are succeeded by the growth of several passengers across the world. In the aviation sector across the globe, the quest for advanced technology, robust systems, and rugged products are ever rising. The technological advancements in the field of aircraft are positively accepted by the developed countries as well as developing regions. The procurement of technologically advanced aircraft has bolstered over the years, flourishing the aircraft component manufacturing market.

The North America compound management market is estimated to grow at a CAGR of 13.9% from 2019 - 2027. The market of compound management in the North America region is majorly contributed by the US. The region is experiencing the robust growth of the market owing to increase in the number of clinical trials along with an increase in R&D expenses made by pharmaceutical companies. The top 10 industry players operating in the market of Compound management across the globe include, , Brooks Life Sciences, Tecan Trading AG, Hamilton Company, TTP Labtech, Frontier Scientific Services, Biosero Inc., Evotec, Icagen, Inc., Wuxi Apptec, and TCG Lifesciences Pvt. Ltd.

Microarrays are the most popular form of lab-on-a-chip technology, due to the wide range of differentiation and low price of the equipment. Increasing use of personal medical devices and the need for immediate results from diagnostic tests are the major factors driving the demand for microarrays in the lab-on-a-chip market. The technological advances have increased the throughput of device production, improved rapid prototyping efforts, and enabled researchers to enhance the complexity and sophistication of experiments that can be performed on a microfluidic chip. As a result, microfluidic technology has its immense potential for research in life science and medicine. In the United States, the usage of high-throughput screening (HTS) technologies increased drastically in academic research. With the rising interest in HTS, the lab-on-chip technology is expected to be widely used in the country, due to its applications in high-throughput screening. The lab-on-a-chip device has its application in the medical field in the diagnosis of various infectious diseases, which eases sample handling and yields efficient results in a snap of time. Thus, the increasing application of LOC in clinical diagnostics is due to its beneficial features, such as low cost, high parallelization, accuracy, and ease-of-use, with low volume sample and faster response time.

The North America mobile cardiac telemetry systems market is estimated to grow at a CAGR of 12.6% from 2019 - 2027. The market of mobile cardiac telemetry systems in the North America region is majorly contributed by the US and US is the largest market for the mobile cardiac telemetry systems. The growth of the market is defined by the availability of the products by the various market leaders, presence of the several companies across the region. In addition, the rise in the cardiovascular diseases are likely to contribute to the growth of the market. The top 10 industry players operating in the market of mobile cardiac telemetry systems across the globe includes Medtronic, BioTelemetry Inc., Applied Cardiac Systems, Inc, Medicomp Inc, Preventice Services, LLC, The Scottcare Corporation, Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A), Zoll Medical Corporation, Welch Allyn, and Telerhythmics, LLC.